Drugmakers compete to launch treatments for blood clots

08/30/2010 | New York Times (tiered subscription model), The

Several companies are racing to develop anti-coagulants to replace warfarin for patients with an increased risk of stroke and blood clots. Experimental anti-clotting drugs apixaban and rivaroxaban are thought to have potential in stroke prevention.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Medical Director - Physician
Willamette Valley Community Health
Salem, OR